Wealth Enhancement Advisory Services’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $681K | Sell |
31,755
-3,579
| -10% | -$76.8K | ﹤0.01% | 1972 |
|
|
2025
Q1 | $857K | Buy |
35,334
+13,915
| +65% | +$337K | ﹤0.01% | 1679 |
|
|
2024
Q4 | $447K | Buy |
21,419
+1,402
| +7% | +$29.3K | ﹤0.01% | 2054 |
|
|
2024
Q3 | $398K | Buy |
20,017
+1,989
| +11% | +$39.5K | ﹤0.01% | 1962 |
|
|
2024
Q2 | $279K | Buy |
18,028
+2,002
| +12% | +$31K | ﹤0.01% | 2030 |
|
|
2024
Q1 | $255K | Buy |
+16,026
| New | +$255K | ﹤0.01% | 2023 |
|
|
2023
Q4 | – | Sell |
-21,326
| Closed | -$249K | – | 2279 |
|
|
2023
Q3 | $249K | Buy |
+21,326
| New | +$249K | ﹤0.01% | 1849 |
|